BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 27262946)

  • 1. Genipin alleviates LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways.
    Zhang A; Wang S; Zhang J; Wu H
    Int Immunopharmacol; 2016 Sep; 38():115-9. PubMed ID: 27262946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
    Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G
    Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fraxin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting the NF-κB and NLRP3 signalling pathways.
    Li W; Li W; Zang L; Liu F; Yao Q; Zhao J; Zhi W; Niu X
    Int Immunopharmacol; 2019 Feb; 67():1-12. PubMed ID: 30530164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
    Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
    Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Casticin inhibits lipopolysaccharide-induced acute lung injury in mice.
    Wang C; Zeng L; Zhang T; Liu J; Wang W
    Eur J Pharmacol; 2016 Oct; 789():172-178. PubMed ID: 27450485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice.
    Du ZA; Sun MN; Hu ZS
    Inflammation; 2018 Feb; 41(1):193-198. PubMed ID: 28986747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of silibinin on LPS-induced acute lung injury by inhibiting NLRP3 and NF-κB signaling pathways.
    Tian L; Li W; Wang T
    Microb Pathog; 2017 Jul; 108():104-108. PubMed ID: 28483599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of NLRP3 and NF-κB signaling pathways by α-Cyperone via activating SIRT1 contributes to attenuation of LPS-induced acute lung injury in mice.
    Liu X; Jin X; Yu D; Liu G
    Int Immunopharmacol; 2019 Nov; 76():105886. PubMed ID: 31520990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
    Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
    J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation.
    Zhang H; Chen S; Zeng M; Lin D; Wang Y; Wen X; Xu C; Yang L; Fan X; Gong Y; Zhang H; Kong X
    Cell Physiol Biochem; 2018; 49(5):1918-1932. PubMed ID: 30235451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of pogostone against LPS-induced acute lung injury in mice via regulation of Keap1-Nrf2/NF-κB signaling pathways.
    Sun CY; Xu LQ; Zhang ZB; Chen CH; Huang YZ; Su ZQ; Guo HZ; Chen XY; Zhang X; Liu YH; Chen JN; Lai XP; Li YC; Su ZR
    Int Immunopharmacol; 2016 Mar; 32():55-61. PubMed ID: 26800098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury.
    Qiushi W; Guanghua L; Guangquan X
    Eur J Pharmacol; 2015 Mar; 750():32-8. PubMed ID: 25620130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice.
    San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N
    Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chikusetsusaponin V attenuates lipopolysaccharide-induced acute lung injury in mice by modulation of the NF-κB and LXRα.
    Su K; Zhang G; Zhang X; Jiang W
    Int Immunopharmacol; 2019 May; 70():174-179. PubMed ID: 30807930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice.
    Chen X; Yang X; Liu T; Guan M; Feng X; Dong W; Chu X; Liu J; Tian X; Ci X; Li H; Wei J; Deng Y; Deng X; Chi G; Sun Z
    Int Immunopharmacol; 2012 Oct; 14(2):209-16. PubMed ID: 22835426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.
    Niu X; Zang L; Li W; Xiao X; Yu J; Yao Q; Zhao J; Ye Z; Hu Z; Li W
    Int Immunopharmacol; 2020 Apr; 81():106024. PubMed ID: 31784404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Garlic oil supplementation blocks inflammatory pyroptosis-related acute lung injury by suppressing the NF-κB/NLRP3 signaling pathway via H
    Dilxat T; Shi Q; Chen X; Liu X
    Aging (Albany NY); 2024 Apr; 16(7):6521-6536. PubMed ID: 38613798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
    Feng G; Sun B; Li TZ
    Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Patchoulene from patchouli oil protects against LPS-induced acute lung injury via suppressing NF-κB and activating Nrf2 pathways.
    Chen XY; Dou YX; Luo DD; Zhang ZB; Li CL; Zeng HF; Su ZR; Xie JH; Lai XP; Li YC
    Int Immunopharmacol; 2017 Sep; 50():270-278. PubMed ID: 28711783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Effect of Amygdalin on LPS-Induced Acute Lung Injury by Inhibiting NF-κB and NLRP3 Signaling Pathways.
    Zhang A; Pan W; Lv J; Wu H
    Inflammation; 2017 Jun; 40(3):745-751. PubMed ID: 28303417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.